Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -$357,440.

  • Cumberland Pharmaceuticals' Net Cash Flow fell 794.06% to -$890,536 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 117.41%. This contributed to the annual value of -$357,440 for FY2024, which is 75.11% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Net Cash Flow stood at -$357,440 for FY2024, which was up 75.11% from -$1.4 million recorded in FY2023.
  • Cumberland Pharmaceuticals' Net Cash Flow's 5-year high stood at $2.3 million during FY2021, with a 5-year trough of -$7.3 million in FY2022.
  • In the last 3 years, Cumberland Pharmaceuticals' Net Cash Flow had a median value of -$1.4 million in 2023 and averaged -$3.0 million.
  • In the last 5 years, Cumberland Pharmaceuticals' Net Cash Flow tumbled by 1,363.85% in 2020 and then spiked by 166.12% in 2021.
  • Cumberland Pharmaceuticals' Net Cash Flow (Yearly) stood at -$3.5 million in 2020, then skyrocketed by 166.12% to $2.3 million in 2021, then crashed by 418.44% to -$7.3 million in 2022, then surged by 80.28% to -$1.4 million in 2023, then skyrocketed by 75.11% to -$357,440 in 2024.